Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012
Expression of insulin-growth factor-I (IGF-I) in alveolar lymphocytes (AL) in interstitial lung diseases (ILD). Potential functions of AL-derived IGF Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005
Analysis of tumor necrosis factor receptor 1 (TNFR1) polymorphisms in patients with cryptogenic fibrosing alveolitis Source: Eur Respir J 2001; 18: Suppl. 33, 411s Year: 2001
Down-regulation of inhibitory of growth family member 4(ING4) in idiopathic pulmonary fibrosis (IPF). Correlation with disease progression Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009
Antifibrotic role of hepatocyte growth factor (HGF) in fibrosing interstial lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 367s Year: 2001
Autocrine expression of mechano and insulin-like 1 growth factors (MGF & IGF-1) in the diaphragm of severe COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 573s Year: 2003
Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007
Expression of transforming growth factor β (TGFβ) receptor, CD105, is declined in Th1 interstitial lung diseases (ILDs) Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011
Expression of epidermal growth factor receptor (EGFR) in the bronchial epithelium of patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011
Increased expression of insulin-like growth factor-binding protein-7 (IGFBP7) in fibroblasts from patients with emphysema Source: Eur Respir J 2004; 24: Suppl. 48, 95s Year: 2004
Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013
Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 823s Year: 2006
Placenta growth factor (PlGF) triggers small airway remodeling (SAR) in chronic obstructive pulmonary disease (COPD) Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia Year: 2017
Insulin-like growth factor-I (IGF-I) in COPD exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002
Insulin-like growth factor-I (IGF-I) in COPD exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 435s Year: 2003
Expression of transforming growth factor (TGF) in bronchial epithelium: association with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 92s Year: 2001
Elevated serum B cell activating factor belonging to the TNF family (BAFF) in interstitial lung diseases associated with collagen vascular disease Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012
The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018
Fibroblast growth factor 23 (FGF23) and hypophosphatemia in patients with COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011